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Abstract
Introduction
• Research has demonstrated that chronic inflammation may drive 
many chronic diseases.
• Despite advances in the treatment of these complex chronic 
diseases their occurrence rates have continued to increase.
• High costs and adverse effects of standard anti-inflammatory 
treatments have prompted patients to seek more cost-effective and 
non-toxic agents for their management. 
• It is estimated that approximately 50% of Americans are 
consuming dietary supplements to promote health and wellness.








• The aim of the present review is to evaluate the efficacy and safety 
of curcumin and fish oil as alternative or adjuvant treatments to 
NSAIDs and immune modulating medications for the treatment of 
chronic inflammation. 
• An online search of CINAHL, PubMed, Cochrane and Alt 
Healthwatch databases was conducted. It was limited to peer-
reviewed articles and clinical trials in academic journals within the 
last ten years. 
• Current research suggests that curcumin may be efficacious in the 
treatment of chronic inflammation. It is generally regarded as safe 
up to 12 gm/day with mild gastrointestinal effects but poor 
bioavailability has limited its clinical application.
• Current research provides evidence that fish oil is efficacious for 
the treatment of chronic inflammation in a variety of chronic 
diseases.  It is generally regarded as safe at doses of 3 gm/day with 
mild gastrointestinal effects and no increased risk of bleeding.
• In vitro studies have demonstrated a synergistic anti-inflammatory 
effect when curcumin and fish oil are used concomitantly.
• In patients with chronic inflammatory processes, is curcumin more 
effective with fewer adverse effects than NSAIDs and immune 
modulating agents at reducing inflammation?
• In patients with chronic inflammatory processes, is fish oil more 
effective and with fewer adverse effects than NSAIDs and immune 
modulating agents at reducing inflammation?
• In patients with chronic inflammatory processes, does concomitant 
administration of curcumin and fish oil elicit a synergistic anti-
inflammatory effect?
Inflammation, Chronic Disease and Anti-Inflammatory Mechanisms 
of Curcumin and Fish Oil
• Chronic inflammation creates a prolonged state of oxidative stress 
and damage which may lead to the progression of many chronic 
inflammatory and degenerative disorders.
• Curcumin exerts its anti-inflammatory effects by downregulating 
inflammatory cytokines, enzymes and transcription factors.
• Fish oil exerts its anti-inflammatory effects by inhibiting neutrophil 
recruitment, blocking production of pro-inflammatory 
prostaglandins, leukotrienes, and cytokines, and inducing 
macrophage phagocytosis and apoptotic cells.
Safety and Efficacy of NSAIDs and Immune Modulating Agents
• Panahi et al. found that in patients with osteoarthritis, analgesics 
and NSAIDs, are only partially efficacious and their long-term use 
has been associated with adverse effects.
• A systematic review by Garg et al. found the use of sulfasalazine, 
mesalamine and immunosuppressives is efficacious for the 
treatment of ulcerative colitis but is associated with high rates of 
adverse effects.
• According to Chandran & Goel common adverse effects include 
gastrointestinal bleeding, fluid retention, renal toxicity, 
cardiovascular effects, accelerated osteoporosis, 
myelosuppression, hepatotoxicity, ocular and auditory toxicity and 
increased risk of infection.
Safety and Efficacy of Curcumin
• Bigford & Rossi found no significant differences in cognitive scores 
and/or biological features of Alzheimer’s disease with unenhanced 
curcumin but found it safe and tolerable up to 12 gms/day.
• Panahi et al. found 1500 mg/day of curcumin enhanced with 
Bioperene may be efficacious in alleviating symptoms without 
significant adverse effects in patients with knee osteoarthritis and 
significantly decreased NSAID use.
(Frequency of the use of NSAIDs/painkillers at baseline and at the 
end of study. Overall, the proportion of subjects reporting no or 
decreased use of NSAIDs (naproxen) at the end of study was 
significantly greater in the curcumin versus placebo group 
(p < 0.001).
• Chandran & Goel found 1 gm/day of enhanced BCM-95 curcumin 
alone or in combination with diclofenac sodium decreased CRP 
levels without any significant adverse effects but was similar if 
efficacy to placebo in reducing joint tenderness and swelling in 
patients with rheumatoid arthritis.
• Panahi et al. found 1 gm/day of curcumin enhanced with piperine
as compared to placebo improves biomarkers of systemic 
antioxidant, lipid peroxidation and inflammation in patients with 
metabolic syndrome.
• Lang et al. found 3 gm/day of unenhanced Cur-Cure curcumin in 
addition to optimized mesalamine therapy was superior to placebo 
in inducing clinical and endoscopic remission without increased 
rates of adverse effects in patients with ulcerative colitis.
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Statement of the Problem
• Non-steroidal anti-inflammatory drugs (NSAIDs) and immune 
modulating medications are the mainstays of treatment for chronic 
inflammation yet their use is associated with a variety of adverse 
effects which can limit or prevent their use.
• Methodologically robust studies are needed to evaluate if dietary 
supplements can be effectively and safely used as alternative or 
adjuvant treatments for chronic inflammation.
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• In patients who desire to use dietary supplements to treat chronic 
inflammation there is evidence that curcumin and fish oil may be 
efficacious with only mild gastrointestinal adverse effects and may 
help reduce NSAID use.
• Curcumin may be efficacious in doses ranging from 500 mg/day 
to 12 mg/day in a variety of chronic diseases. A bioavailability 
enhanced formulation should be used.
• Fish oil may be efficacious in a variety of chronic diseases at a 
dose of 3 gm/day with no increased risk of bleeding.  There does 
not appear to be evidence to support the efficacy and safety of 
higher doses.
Safety and Efficacy of Fish Oil
• Arriens et al. found fish oil improves quality of life, disease 
activity, and biomarkers of inflammation with only mild 
gastrointestinal adverse effects in patients with SLE.
• A meta-analysis by Goldberg & Katz found fish oil improves pain 
outcomes and reduced NSAID consumption at doses above 2.7 
gm/day in patients with rheumatoid arthritis.
• A systematic review by Lev-Tzion et al. found no evidence of 
benefit of fish oil in maintaining remission of Crohn’s disease but 
found no serious side effects.
Synergistic Effects of Curcumin and Fish Oil
• Saw et al. found that curcumin and fish oil in vitro had a 
synergistic anti-inflammatory effect and concluded there is strong 
evidence these effects may be translated into human trials.
• Current mainstays of treatment for chronic inflammation are 
NSAIDs and immune-modulating medications which are associated 
with high rates of adverse effects.
• Current literature appears to provide evidence that curcumin may be 
efficacious in the treatment of chronic inflammation in a variety of 
chronic diseases with only mild gastrointestinal adverse effects 
should its limitations with poor bioavailability be overcome.
• Current literature supports that fish oil taken at doses of > 2.7 
gm/day is efficacious in reducing inflammation in a variety of chronic 
diseases and is safe up to 3 mg daily with only mild gastrointestinal 
adverse effects even in patients with high bleeding risk.
• Studies indicate that curcumin and fish oil may be a reasonable 
alternative or adjunctive therapy in the treatment of chronic 
inflammatory conditions and may decrease the need for NSAIDs and 
immune modulating agents thus decreasing their adverse side effects. 
• Due to different mechanisms of action in vitro studies provide 
evidence of a synergistic anti-inflammatory effect when curcumin 
and fish oil are given concomitantly.  Human studies are needed.
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